analyst
AR
NASDAQ · ARVN
Arvinas, Inc.
Healthcare · Biotechnology
$8.51
Up+$0.21 (+2.53%)
Updated Sep 23, 2026, 8:08 AM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 974.25M
- P/E ratio
- -10.66
- Dividend yield
- 0.00%
- 52-week range
- $6.97 – $14.51
- Volume
- 685.2K
- Avg. volume
- 876.56K
Price performance
ARVN price history
1M range · 20 trading sessions · Daily adjusted prices
ARVN closed at $8.51 after 20 trading sessions, down 11.35% for the selected period.
- Last close
- $8.51
- Period change
- -11.35%
- Period low
- $8.16
- Period high
- $9.60
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | $8.37 | $8.57 | $8.30 | $8.51 | 685.2K |
| Sep 21, 2026 | $8.37 | $8.44 | $8.21 | $8.30 | 639.84K |
| Sep 18, 2026 | $8.29 | $8.35 | $8.1901 | $8.29 | 1.78M |
| Sep 17, 2026 | $8.29 | $8.46 | $8.17 | $8.31 | 533.21K |
| Sep 16, 2026 | $8.31 | $8.325 | $8.05 | $8.16 | 742.62K |
| Sep 15, 2026 | $8.34 | $8.385 | $8.09 | $8.26 | 2.52M |
| Sep 14, 2026 | $8.49 | $8.70 | $8.39 | $8.40 | 1.47M |
| Sep 11, 2026 | $8.82 | $8.915 | $8.365 | $8.45 | 908.56K |
| Sep 10, 2026 | $8.67 | $8.775 | $8.47 | $8.71 | 776.73K |
| Sep 9, 2026 | $9.085 | $9.10 | $8.75 | $8.76 | 738.47K |
| Sep 8, 2026 | $9.23 | $9.34 | $8.97 | $9.08 | 570.72K |
| Sep 4, 2026 | $9.31 | $9.455 | $9.22 | $9.39 | 449.3K |
| Sep 3, 2026 | $9.68 | $9.691 | $9.21 | $9.31 | 501.48K |
| Sep 2, 2026 | $9.28 | $9.64 | $9.27 | $9.59 | 548.8K |
| Sep 1, 2026 | $9.14 | $9.30 | $9.0601 | $9.28 | 491.14K |
| Aug 31, 2026 | $9.12 | $9.27 | $8.9601 | $9.20 | 659.72K |
| Aug 28, 2026 | $9.17 | $9.235 | $9.03 | $9.18 | 600.34K |
| Aug 27, 2026 | $9.27 | $9.43 | $9.15 | $9.24 | 527.01K |
| Aug 26, 2026 | $9.53 | $9.545 | $9.28 | $9.32 | 532.59K |
| Aug 25, 2026 | $9.39 | $9.74 | $9.39 | $9.60 | 530.61K |
Latest ARVN news
The latest Smart Investors Daily articles mentioning ARVN.
Stock researchCompany · Forecast
Loading stock research…